急性缺血性卒中出血转化的临床与影像标志物
该研究为MR CLEAN试验的事后分析,纳入478例有随访影像的急性缺血性卒中患者,46%发生出血转化。基线NIHSS评分和侧支循环不良与出血性梗死相关,收缩压升高和房颤与脑实质血肿相关,收缩压升高和抗血小板使用与症状性颅内出血相关。
要点
- 基线NIHSS评分升高和侧支循环不良与出血性梗死独立相关。
- 收缩压升高和房颤与脑实质血肿独立相关。
- 收缩压升高和抗血小板使用与症状性颅内出血独立相关。
核心结论
- 临床和影像学卒中严重程度参数与出血性梗死和脑实质血肿均相关。
- 基线患者特征如收缩压、房颤和抗血小板使用仅与脑实质血肿或症状性颅内出血相关。
研究设计与样本
- MR CLEAN试验的事后分析,纳入478例有随访影像的急性缺血性卒中患者。
- 出血转化按ECASS II标准分类,采用多变量logistic回归分析。
主要发现
- 478例患者中46%(n=222)发生出血转化,其中66%(n=147)为出血性梗死,34%(n=75)为脑实质血肿。
- 症状性颅内出血占全部患者的7.3%(n=35)。
- 基线NIHSS评分每增加1分与出血性梗死相关(OR 1.05,95%CI 1.01-1.09)。
- 侧支循环缺失/不良与出血性梗死相关(OR 1.90,95%CI 1.05-3.42)。
- 收缩压每增加10 mmHg与脑实质血肿相关(OR 1.17,95%CI 1.05-1.31),房颤与脑实质血肿相关(OR 1.94,95%CI 1.08-3.48)。
临床怎么用
- 对于急性缺血性卒中患者,应评估基线NIHSS评分和侧支循环状态以识别出血性梗死高风险者。
- 管理收缩压和评估房颤、抗血小板使用有助于识别脑实质血肿或症状性颅内出血高风险患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Hemorrhagic transformation (HT) after acute ischemic stroke may cause severe neurological deterioration and affects functional outcome. Identifying patients most likely to suffer from this complication could potentially be used for future treatment selection. Reperfusion after endovascular therapy could be associated with different risk factors for HT than intravenous thrombolytics as these treatments largely differ. In this study, we aimed to identify clinical and imaging markers that are associated with HT subtypes in the MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands) population. Methods- In this post hoc analysis, all patients with follow-up imaging were included. HT was classified according to ECASS II (European Cooperative Acute Stroke Study). Variables with an association of P<0.1 were included in the multivariable logistic regression to identify clinical and radiological variables associated with petechial hemorrhagic infarction, parenchymal hematoma (PH), and symptomatic intracranial hemorrhage. Results- Of the 478 out of 500 included patients in this subanalysis, 46% had HT (n=222). Of these, 66% had hemorrhagic infarction (n=147) and 34% PH (n=75). Symptomatic intracranial hemorrhage was observed in 7.3% (n=35) of all patients. Baseline National Institutes of Health Stroke Scale (odds ratio [OR], 1.05,95% CI, 1.01-1.09 per point) and absent/poor collaterals (OR, 1.90; 95% CI, 1.05-3.42) were significantly associated with hemorrhagic infarction. Increased systolic blood pressure (OR, 1.17; 95% CI, 1.05-1.31 per 10 mm Hg) and atrial fibrillation (OR, 1.94; 95% CI, 1.08-3.48) were associated with PH. Increased systolic blood pressure (OR, 1.28; 95% CI, 1.12-1.48) and antiplatelet use (OR, 2.6; 95% CI, 1.08-6.3) were associated with symptomatic intracranial hemorrhage. Conclusions- Clinical and imaging stroke severity parameters were associated with HT, both in hemorrhagic infarction and PH, whereas baseline patients characteristics like systolic blood pressure, atrial fibrillation, and antiplatelet use were only associated with PH or symptomatic intracranial hemorrhage. Clinical Trial Registration- URL: http://www.controlled-trials.com. Unique identifier: ISRCTN10888758.
引用
- van Kranendonk KR, Treurniet KM, Boers AMM, et al. Clinical and Imaging Markers Associated With Hemorrhagic Transformation in Patients With Acute Ischemic Stroke. Stroke. 2019. PMID: 33755497. doi:10.1161/STROKEAHA.118.024255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。